Rick Wise
Stock Analyst at Stifel
(4.39)
# 355
Out of 4,913 analysts
238
Total ratings
65.8%
Success rate
11.57%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Buy | $90 → $95 | $78.49 | +21.03% | 24 | Jul 25, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $138 → $115 | $95.98 | +19.82% | 15 | May 6, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $280 → $224 | $182.94 | +22.44% | 8 | May 2, 2025 | |
| CNMD CONMED | Downgrades: Hold | $75 → $55 | $50.02 | +9.96% | 11 | Apr 28, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $135 → $145 | $126.35 | +14.76% | 20 | Apr 17, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $28 | $16.50 | +69.70% | 1 | Mar 31, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $40 → $32 | $22.39 | +42.92% | 6 | Mar 5, 2025 | |
| LIVN LivaNova | Maintains: Buy | $72 → $60 | $43.46 | +38.06% | 6 | Feb 26, 2025 | |
| AORT Artivion | Maintains: Buy | $33 → $30 | $31.31 | -4.18% | 6 | Feb 25, 2025 | |
| ATRC AtriCure | Maintains: Buy | $36 → $48 | $33.22 | +44.49% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $120 | $105.84 | +13.38% | 17 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $400.69 | +9.81% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $170 → $155 | $166.22 | -6.75% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $493.95 | +23.49% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $162.07 | +17.23% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $28.52 | +33.24% | 8 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $8 | $5.75 | +39.13% | 8 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $3.09 | +417.80% | 4 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $82 | $73.77 | +11.16% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $102 | $77.74 | +31.21% | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $85 → $87 | $91.97 | -5.40% | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $5.70 | +110.53% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $82.91 | -9.54% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $16.84 | +42.52% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $390 → $90 | $18.04 | +398.89% | 4 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $12.01 | +108.16% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $57.91 | +93.40% | 5 | Oct 2, 2020 |
Edwards Lifesciences
Jul 25, 2025
Maintains: Buy
Price Target: $90 → $95
Current: $78.49
Upside: +21.03%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Buy
Price Target: $138 → $115
Current: $95.98
Upside: +19.82%
Becton, Dickinson and Company
May 2, 2025
Maintains: Buy
Price Target: $280 → $224
Current: $182.94
Upside: +22.44%
CONMED
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $50.02
Upside: +9.96%
Abbott Laboratories
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $126.35
Upside: +14.76%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $16.50
Upside: +69.70%
OrthoPediatrics
Mar 5, 2025
Maintains: Buy
Price Target: $40 → $32
Current: $22.39
Upside: +42.92%
LivaNova
Feb 26, 2025
Maintains: Buy
Price Target: $72 → $60
Current: $43.46
Upside: +38.06%
Artivion
Feb 25, 2025
Maintains: Buy
Price Target: $33 → $30
Current: $31.31
Upside: -4.18%
AtriCure
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $33.22
Upside: +44.49%
Feb 10, 2025
Maintains: Buy
Price Target: $115 → $120
Current: $105.84
Upside: +13.38%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $400.69
Upside: +9.81%
Jan 23, 2025
Maintains: Hold
Price Target: $170 → $155
Current: $166.22
Upside: -6.75%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $493.95
Upside: +23.49%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $162.07
Upside: +17.23%
Nov 11, 2024
Maintains: Buy
Price Target: $46 → $38
Current: $28.52
Upside: +33.24%
Nov 6, 2024
Maintains: Hold
Price Target: $7 → $8
Current: $5.75
Upside: +39.13%
Oct 31, 2024
Maintains: Buy
Price Target: $17 → $16
Current: $3.09
Upside: +417.80%
Oct 8, 2024
Initiates: Buy
Price Target: $82
Current: $73.77
Upside: +11.16%
Sep 30, 2024
Maintains: Buy
Price Target: $100 → $102
Current: $77.74
Upside: +31.21%
Aug 21, 2024
Maintains: Hold
Price Target: $85 → $87
Current: $91.97
Upside: -5.40%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $5.70
Upside: +110.53%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $82.91
Upside: -9.54%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $16.84
Upside: +42.52%
Oct 13, 2023
Maintains: Buy
Price Target: $390 → $90
Current: $18.04
Upside: +398.89%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $12.01
Upside: +108.16%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $57.91
Upside: +93.40%